{"id":"https://openalex.org/W2582999888","doi":"https://doi.org/10.1182/blood.v124.21.4507.4507","title":"Pre-Clinical Characterization of T Cell-Dependent Bispecific Antibody Anti-CD79b/CD3 As a Potential Therapy for B Cell Malignancies","display_name":"Pre-Clinical Characterization of T Cell-Dependent Bispecific Antibody Anti-CD79b/CD3 As a Potential Therapy for B Cell Malignancies","publication_year":2014,"publication_date":"2014-12-06","ids":{"openalex":"https://openalex.org/W2582999888","doi":"https://doi.org/10.1182/blood.v124.21.4507.4507","mag":"2582999888"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v124.21.4507.4507","doi":"https://doi.org/10.1182/blood.v124.21.4507.4507","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.4507.4507","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011859932","display_name":"Lin Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"L. Laura Sun","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043234638","display_name":"Xiaocheng Chen","orcid":"https://orcid.org/0000-0003-1292-7084","observed_orcids":["https://orcid.org/0000-0003-1292-7084"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Xiaocheng Chen","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056297995","display_name":"Yvonne Chen","orcid":"https://orcid.org/0000-0001-8844-7891","observed_orcids":["https://orcid.org/0000-0001-8844-7891","https://orcid.org/0000-0003-4755-6025"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yvonne Chen","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088134239","display_name":"Mark S. Dennis","orcid":"https://orcid.org/0000-0003-3581-2917","observed_orcids":["https://orcid.org/0000-0003-3581-2917"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark S. Dennis","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067027064","display_name":"Diego A. Ellerman","orcid":"https://orcid.org/0000-0002-3056-3600","observed_orcids":["https://orcid.org/0000-0002-3056-3600"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Diego Ellerman","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110321226","display_name":"Clarissa Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Clarissa Johnson","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069254746","display_name":"Mary A. Mathieu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mary Mathieu","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066830159","display_name":"Amy Oldendorp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Amy Oldendorp","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022150086","display_name":"Andrew G. Polson","orcid":"https://orcid.org/0000-0003-3289-6502","observed_orcids":["https://orcid.org/0000-0003-3289-6502"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew G. Polson","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111882044","display_name":"Arthur E. Reyes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Arthur Reyes","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066511649","display_name":"Eric Gary Stefanich","orcid":"https://orcid.org/0000-0002-9907-2754","observed_orcids":["https://orcid.org/0000-0002-9907-2754"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Eric Stefanich","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hong Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hong Wang","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029086828","display_name":"Peiyin Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Peiyin Wang","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025817932","display_name":"Bing Zheng","orcid":"https://orcid.org/0000-0003-3443-7297","observed_orcids":["https://orcid.org/0000-0003-3443-7297"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bing Zheng","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072076025","display_name":"Allen J. Ebens","orcid":"https://orcid.org/0000-0001-9678-2411","observed_orcids":["https://orcid.org/0000-0001-9678-2411"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allen J. Ebens","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5011859932","https://openalex.org/A5025817932","https://openalex.org/A5029086828","https://openalex.org/A5043234638","https://openalex.org/A5056297995","https://openalex.org/A5066511649","https://openalex.org/A5066830159","https://openalex.org/A5067027064","https://openalex.org/A5069254746","https://openalex.org/A5088134239","https://openalex.org/A5110321226","https://openalex.org/A5111882044"],"corresponding_institution_ids":["https://openalex.org/I183934855"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.2595,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.65228088,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"124","issue":"21","first_page":"4507","last_page":"4507"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd79b","display_name":"CD79b","score":0.8840000033378601},{"id":"https://openalex.org/keywords/cd3","display_name":"CD3","score":0.7350000143051147},{"id":"https://openalex.org/keywords/b-cell-malignancies","display_name":"B-cell malignancies","score":0.859000027179718},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.722000002861023},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.5049999952316284},{"id":"https://openalex.org/keywords/binding-affinity","display_name":"binding affinity","score":0.5619999766349792},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.5630000233650208},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.6179999709129333},{"id":"https://openalex.org/keywords/cynomolgus-monkeys","display_name":"Macaca fascicularis","score":0.8059999942779541},{"id":"https://openalex.org/keywords/antibody-aggregation","display_name":"antibody aggregation","score":0.41100001335144043},{"id":"https://openalex.org/keywords/b-cell-leukemia","display_name":"B-cell leukemia","score":0.3449999988079071}],"concepts":[{"id":"https://openalex.org/C2778020697","wikidata":"https://www.wikidata.org/wiki/Q410189","display_name":"Blinatumomab","level":4,"score":0.7444852590560913},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6917489767074585},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.5848200917243958},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5228731632232666},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4570664167404175},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4363189935684204},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4273574948310852},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.42706042528152466},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.414936363697052},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4003838896751404},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.2897018790245056},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.24386918544769287}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v124.21.4507.4507","doi":"https://doi.org/10.1182/blood.v124.21.4507.4507","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.4507.4507","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2741327247","https://openalex.org/W2104173785","https://openalex.org/W4225281122","https://openalex.org/W4291237207","https://openalex.org/W1987913042","https://openalex.org/W2336995415","https://openalex.org/W2194924429","https://openalex.org/W2026023404","https://openalex.org/W116285198","https://openalex.org/W2554618617"],"abstract_inverted_index":{"Abstract":[0],"T-cell":[1,84,114,270],"recruiting":[2],"bispecific":[3,55,86,291],"antibodies":[4,56,87,126,292,322],"and":[5,57,65,69,82,156,159,195,197,210,233,240,273,381],"antibody":[6,45,80,129,165],"fragments":[7,46,58],"have":[8,28,75],"been":[9,29,199],"used":[10],"to":[11,93,108,185,290,302],"harness":[12],"the":[13,32,49,100,109,113,139,177,253,332,349,353,360],"cytotoxic":[14,335],"potential":[15,362],"of":[16,42,52,112,176,238,255,285,321,326,337,347,363],"T":[17,104],"cells":[18,105,250,377],"for":[19,214,396],"cancer":[20],"treatment.":[21],"As":[22],"an":[23,203],"example,":[24],"encouraging":[25],"clinical":[26,397],"responses":[27],"reported":[30,54],"with":[31,127,281,312,323,343],"B":[33,96,117,151,168,178,186,192,215,258,265,296,308,333,375,400],"cell":[34,97,118,152,169,179,193,216,266,279,297,309,334,401],"targeting":[35,119,293],"Blinatumomab,":[36],"a":[37,70,77,174,208,245,269,282,324,393],"55-kDa":[38],"fusion":[39],"protein":[40],"composed":[41],"two":[43],"single-chain":[44],"(scFvs).":[47],"However,":[48],"therapeutic":[50,212,361],"promise":[51],"many":[53],"is":[59,172,183,188,244,274,371],"often":[60],"limited":[61],"by":[62,106,202],"unfavorable":[63],"pharmacokinetics":[64],"administration":[66],"schedule,":[67],"immunogenicity,":[68],"propensity":[71],"towards":[72],"aggregation.":[73],"We":[74],"adopted":[76],"knobs-into-holes":[78],"(KIH)":[79],"format":[81,141],"produced":[83,232],"dependent":[85,271],"(TDB),":[88],"which":[89],"allow":[90],"one":[91],"arm":[92,102,351,355],"target":[94,213],"various":[95],"antigens":[98],"while":[99],"other":[101,295],"recruits":[103],"binding":[107,327,345],"CD3e":[110],"subunit":[111],"receptor.":[115],"These":[116],"TDBs":[120,142],"are":[121,143],"full":[122],"length,":[123],"humanized":[124],"IgG1":[125],"natural":[128],"architecture.":[130],"Single":[131],"dose":[132],"pharmacokinetic/pharmacodynamic":[133],"studies":[134],"in":[135,146,149,154,252,268,306,356,373,399],"cynomolgus":[136],"monkeys":[137],"show":[138,226,330],"KIH":[140],"well":[144],"tolerated":[145],"life,":[147],"result":[148],"potent":[150,264,305],"depletion":[153],"peripheral":[155],"lymphoid":[157],"tissue,":[158],"demonstrate":[160,368],"pharmacokinetic":[161],"properties":[162],"resembling":[163],"conventional":[164],"therapy.":[166],"One":[167],"antigen":[170,287],"targeted":[171],"CD79b,":[173],"component":[175],"receptor":[180],"complex.":[181],"CD79b":[182,256,286],"restricted":[184],"cells,":[187],"highly":[189],"prevalent":[190],"on":[191],"leukemia":[194,380],"lymphomas,":[196],"has":[198],"clinically":[200],"validated":[201],"anti-CD79b":[204,350],"antibody-drug":[205],"conjugate":[206],"as":[207],"safe":[209],"effective":[211],"malignancies":[217],"(ASCO":[218],"2014":[219],"abstract#8519).":[220],"In":[221,260],"our":[222],"present":[223],"work,":[224],"we":[225,329,366],"that":[227,331,369],"anti-CD79b/CD3":[228,299,338,364,389],"TDB":[229,243,300,339,390],"can":[230,340],"be":[231,303,341,392],"purified":[234],"from":[235,316,379],"E.coli,":[236],"free":[237],"homodimer":[239],"aggregates.":[241],"Anti-CD79b/CD3":[242],"conditional":[246],"agonist,":[247],"activating":[248],"CD3+T":[249],"only":[251],"presence":[254],"expressing":[257],"cells.":[259],"vitro,":[261],"it":[262,370],"induces":[263],"killing":[267,310,374],"manner,":[272],"broadly":[275],"active":[276,372],"against":[277],"lymphoma":[278,376,382],"lines":[280],"wide":[283],"range":[284,325],"levels.":[288],"Compared":[289],"some":[294],"antigens,":[298],"appears":[301],"more":[304],"autologous":[307],"assays":[311],"human":[313],"PBMCs":[314],"isolated":[315,378],"healthy":[317],"donors.":[318],"Taking":[319],"advantage":[320],"affinities,":[328],"potency":[336],"enhanced":[342],"increased":[344],"affinity":[346],"either":[348],"or":[352],"anti-CD3":[354],"vitro.":[357],"To":[358],"assess":[359],"TDB,":[365],"further":[367],"patients.":[383],"Collectively,":[384],"these":[385],"preclinical":[386],"data":[387],"suggest":[388],"may":[391],"promising":[394],"agent":[395],"development":[398],"malignancies.":[402],"Disclosures":[403],"Sun:":[404],"Genentech:":[405],"Employment.":[406,408,410,412,414,416,418,420,422,424,426,428,430,432,434],"Chen:Genentech:":[407,409],"Dennis:Genentech:":[411],"Ellerman:Genentech:":[413],"Johnson:Genentech:":[415],"Mathieu:Genentech:":[417],"Oldendorp:Genentech:":[419],"Polson:Genentech:":[421],"Reyes:Genentech:":[423],"Stefanich:Genentech:":[425],"Wang:Genentech:":[427,429],"Zheng:Genentech:":[431],"Ebens:Genentech:":[433]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-02-03T00:00:00"}